Yellow mercuric oxide: a treatment of choice for phthiriasis palpebrarum. (41/76)

Thirty-five patients presenting with phthiriasis palpebrarum were all treated with a regimen of 1% yellow oxide of mercury ointment four times daily for 14 days. At the conclusion of treatment there was complete resolution of the signs and symptoms of the disease. No side effects due to the treatment were reported or detected. We have shown that 1% mercuric oxide ointment is both a safe and effective treatment for phthiriasis palpebrarum. We recommend it as the treatment of choice.  (+info)

In vitro studies evaluating leaching of mercury from mine waste calcine using simulated human body fluids. (42/76)

 (+info)

Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor. (43/76)

 (+info)

Dental devices: classification of dental amalgam, reclassification of dental mercury, designation of special controls for dental amalgam, mercury, and amalgam alloy; technical amendment. Final rule; technical amendment. (44/76)

The Food and Drug Administration (FDA) published a final rule in the Federal Register of August 4, 2009 (74 FR 38686) which classified dental amalgam as a class II device, reclassified dental mercury from class I to class II, and designated special controls for dental amalgam, mercury, and amalgam alloy. The effective date of the rule was November 2, 2009. The final rule was published with an inadvertent error in the codified section. This document corrects that error. This action is being taken to ensure the accuracy of the agency's regulations.  (+info)

Voltammetric determination of ferulic acid by didodecyldimethylammonium bromide/nafion composite film-modified carbon paste electrode. (45/76)

A simple and rapid method for the determination of ferulic acid in pharmaceutical formulations by didodecyldimethylammonium bromide (DDAB)/Nafion composite film-modified carbon paste electrode is presented. The electrochemical behavior of ferulic acid at the proposed electrode was investigated by cyclic voltammetry and a well-defined oxidation peak was observed at +0.44 V versus saturated calomel electrode in 0.1 M acetate buffer (pH 5.5) solutions. Some experimental parameters affecting the electrochemical response of the modified electrode were optimized. Under optimal conditions, the oxidation peak currents of ferulic acid increase linearly with the concentration of ferulic acid in the range from 2.0 x 10(-6) to 1.2 x 10(-4) M with a detection limit of 3.9 x 10(-7) M (S/N = 3). The proposed method was successfully applied to the determination of ferulic acid in pharmaceutical tablets.  (+info)

Curli produced by Escherichia coli PHL628 provide protection from Hg(II). (46/76)

 (+info)

Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning. (47/76)

 (+info)

Mercury exposure and children's health. (48/76)

 (+info)